Abstract

Compounding for the Pediatric Patient

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 1997 - Pediatric Care

Page(s): 84-86

Download in electronic PDF format for $75

Abstract

This article covers dosage forms for pediatric patients, customizing pediatric dosage forms, formulation factors, counseling the caregiver and beyond pediatrics. Tables provide information regarding approximate pH values and alcohol content for some common vehicles and suspending agents for extemporaneous preparation of suspensions.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 1997 Pg. 84-86	Compounding for the Pediatric Patient Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 9-12	Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Author(s): Schotik Debora
Jul/Aug 1999 Pg. 274-276	Extemporaneous Formulations in Pediatric Patients Author(s): Nahata Milap C
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Nov/Dec 2005 Pg. 456-461	Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Author(s): Fonseca Simonne C
Jan/Feb 2009 Pg. 6-12	Compounding for Pediatric Patients: Case Reports and Formulations Author(s): Mixon William, Angelle Patricea, Yoch Douglas
May/Jun 2009 Pg. 224-229	Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education Author(s): McElhiney Linda F
Jan/Feb 2016 Pg. 6-10	Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Author(s): Choo Winnie
Jul/Aug 2003 Pg. 258-263	Patient Satisfaction with Pharmacist Intervention and Consultation in HRT Author(s): DiMaggio Jennifer Lyn, Reed-Kane Dana
Jul/Aug 2019 Pg. 324-331	Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
Nov/Dec 2002 Pg. 424-425	Book Reviews: Compounding for Pediatric Patients Author(s): Ashworth Lisa D, Reed-Kane Dana
Nov/Dec 2003 Pg. 441-447	Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care Author(s): Fassett William E
Jul/Aug 2013 Pg. 339-343	Patient-centered Care as Value-added Service by Compounding Pharmacists Author(s): McPherson Timothy B, Fontane Patrick E, Day Jonathan R
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
May/Jun 2011 Pg. 194-199	Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
Jul/Aug 2011 Pg. 316-319	Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient Author(s): Bramwell Bethany
Nov/Dec 2003 Pg. 490-494	Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations Author(s): Branvold Andrea, Barner Jamie C
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 328-331	Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Author(s): Okeke Claudia C, Allen Loyd V Jr